All the information you need about SOFT MEDICAL AESTHETICS to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2022-10-13 | Partially confidential | 2021-12-31 | Complete |
| 2021-10-06 | Partially confidential | 2020-12-31 | Complete |
| 2020-11-30 | Partially confidential | 2019-12-31 | Complete |
| 2019-07-10 | Partially confidential | 2018-12-31 | Complete |
| 2018-07-06 | Partially confidential | 2017-12-31 | Complete |
| 2018-01-17 | Partially confidential | 2016-12-31 | Complete |
| Name | SOFT MEDICAL AESTHETICS |
| Siren | 518712120 |
| Closing | 2020-12-31 |
| Registry code | 7501 |
| Registration number | 112354 |
| Management number | 2009B22670 |
| Activity code | 4646Z |
| Closing date n-1 | 2019-12-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 12 |
| Filing date | 2021-10-06 |
| Modification | 00 Annual accounts entered without anomaly |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Partially confidential |
| Address | 75017 PARIS |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
AB Establishment Expenses | ||||
AF Concessions, Patents and Similar Rights | 583 480.00 | 361 880.00 | 221 600.00 | 583 480.00 |
AJ Other Intangible Assets | ||||
AT Other tangible assets | 114 699.00 | 55 271.00 | 59 427.00 | 114 699.00 |
BH Other financial assets | 27 047.00 | 27 047.00 | 27 047.00 | |
BJ TOTAL (I) | 898 969.00 | 585 051.00 | 313 918.00 | 898 969.00 |
BL Raw materials, supplies | 37 478.00 | 37 478.00 | 37 478.00 | |
BT Goods | 565 257.00 | 44 957.00 | 520 300.00 | 565 257.00 |
BX Customers and related accounts | 215 722.00 | 215 722.00 | 215 722.00 | |
BZ Other receivables | 766 202.00 | 766 202.00 | 766 202.00 | |
CF Cash and cash equivalents | 465 480.00 | 465 480.00 | 465 480.00 | |
CH Prepaid expenses | 173 756.00 | 173 756.00 | 173 756.00 | |
CJ TOTAL (II) | 2 223 896.00 | 44 957.00 | 2 178 939.00 | 2 223 896.00 |
CO Grand total (0 to V) | 3 122 865.00 | 630 008.00 | 2 492 858.00 | 3 122 865.00 |
CU Other investments | 1 278.00 | 1 278.00 | 1 278.00 | |
CX Development or Research and Development Expenses | 172 466.00 | 167 899.00 | 4 566.00 | 172 466.00 |
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 10 000.00 | 10 000.00 | 10 000.00 | |
DD Legal reserve (1) | 1 000.00 | 1 000.00 | 1 000.00 | |
DH Retained earnings | 1 060 703.00 | 695 498.00 | 1 060 703.00 | |
DI RESULTS FOR THE YEAR (Profit or Loss) | 72 027.00 | 365 205.00 | 72 027.00 | |
DL TOTAL (I) | 1 143 730.00 | 1 071 703.00 | 1 143 730.00 | |
DU Loans and Debts from Credit Institutions (3) | 726 942.00 | 70 864.00 | 726 942.00 | |
DX Trade payables and related accounts | 372 127.00 | 201 961.00 | 372 127.00 | |
DY Tax and social security liabilities | 248 921.00 | 200 773.00 | 248 921.00 | |
EA Other liabilities | 1 138.00 | 8 251.00 | 1 138.00 | |
EC TOTAL (IV) | 1 349 128.00 | 481 849.00 | 1 349 128.00 | |
EE Grand total (I to V) | 2 492 858.00 | 1 553 552.00 | 2 492 858.00 | |
EG Accrued income and payables due within one year | 1 349 128.00 | 481 849.00 | 1 349 128.00 | |
